FIG (NYSE: FIG) insider files to sell 62,500 Class A shares
Rhea-AI Filing Summary
FIG filed a notice to sell insider shares. The filing covers a planned sale of 62500 shares of Class A Common Stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 2097500.00. These shares are part of an issuer with 415909379 shares outstanding and are expected to be sold on or about 01/14/2026 on the NYSE.
The 62500 shares were originally acquired on 10/26/2012 as founder shares from the issuer. Over the past three months, related 10b5-1 sales have already occurred, including 250000-share and 62500-share trades for Dylan Field and LLL INVESTMENTS LLC on 11/24/2025 and 12/15/2025, plus a separate sale of 3029063 shares of Class A Common Stock for gross proceeds of 112985564.43 on 11/17/2025.
Positive
- None.
Negative
- None.
FAQ
What does FIGs latest Form 144 filing disclose?
The filing discloses an intended sale of 62500 shares of FIG Class A Common Stock with an aggregate market value of 2097500.00, to be sold on or about 01/14/2026 on the NYSE.
How many FIG shares are outstanding in this Form 144?
The Form 144 lists 415909379 shares of Class A Common Stock outstanding for the issuer.
How and when were the FIG shares in this Form 144 originally acquired?
The 62500 shares to be sold were acquired on 10/26/2012 as founder shares from the issuer, with the nature of payment shown as N/A.
Which broker will handle the FIG Form 144 share sale?
The planned FIG share sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
What recent FIG insider sales are reported for the past 3 months?
The filing lists several recent 10b5-1 sales of FIG Class A Common Stock, including 250000-share and 62500-share trades for Dylan Field and LLL INVESTMENTS LLC on 11/24/2025 and 12/15/2025, plus a separate sale of 3029063 shares on 11/17/2025 for gross proceeds of 112985564.43.
What trading plan information is referenced in the FIG Form 144?
The Form 144 references Rule 10b5-1 sales and includes a representation that the person for whose account the securities are to be sold does not know any undisclosed material adverse information about the issuers current or prospective operations.